Karim Budhwani, PhD

Birmingham, Alabama, United States
Dr. Karim Budhwani co-founded CerFlux, Inc. in 2018 to #CrushCancer by developing personalized medicine technology using advances in micro and nanomedicine. Dr. Budhwani also serves as Visiting Scientist in the Dept. of Physics at Coe College and in the Heersink School of Medicine at UAB. He is Venture Partner at FundRx, Dir. of Vision and Strategy at TruSpin, and Ambassador at the Center for Advancing Innovation. He has also served as Ambassador of Trade for the State of Alabama and as Chair of the Ismail Professionals Network which spans over 20 countries on 5 continents. He is well published in business and peer-reviewed journals. His scientific research is well funded including prestigious grants from the National Science Foundation (NSF) and the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

Dr. Budhwani also served in various capacities to combat COVID-19 including attenuating pandemic induced supply shocks with locally sourced materials and engineering capacity, realigning COVID-19 testing along population density, developing and instituting strategies for reopening schools safely, and an inverted approach to economic stimulus packages that saves lives, livelihoods, and quality of life. Yes, he is working to crush both cancer and COVID-19.

He received his BA in Computer Science, Economics, and Business from Coe College, IA (1993), MS in Biomedical Engineering from UAB (2015), and PhD in Materials Science and Engineering (Nanomedicine) from UAB and UA in 2018. For decades of leadership in advancing innovation, excellence, service, and his vision for undergirding the new knowledge society, Coe College invited him to deliver the commencement address and conferred upon him an honorary doctorate, Doctor of Liberal Arts (DLA), in 2018. Dr. Budhwani has won numerous awards and honors but among his most cherished honors is the title of #CancerKiller bestowed upon him by friends of his then 8-year-old sons.
Speaking In
11:00 AM - 12:00 PM (PDT)
Wednesday, June 15
 With a 90% failure rate and tens of billions in lost R&D costs every year, there is no…